Respiro is a connected respiratory disease management platform that enables advanced tracking of medications and monitoring of treatment effectiveness for improved adherence and reduced hospitalizations.

We apply advanced machine learning to measure medication use with digital sensors. These sensors are certified medical devices (CE class IIa) that attach as add-ons to existing conventional inhalers without the need of changing the design or the aerodynamic behaviour of the inhaler flow path. The data collected by the sensors is critical for understanding the real-life use and the effectiveness of inhaled medications, and for the development of interventions promoting adherence and correct inhaler technique.
Also, we use deep learning and software applications to deliver data-driven therapies. A patient mobile application provides personalized support to help simplify the management of the treatment, control the disease and improve the patient experience. A professional-oriented da...
Respiro is a connected respiratory disease management platform that enables advanced tracking of medications and monitoring of treatment effectiveness for improved adherence and reduced hospitalizations.

We apply advanced machine learning to measure medication use with digital sensors. These sensors are certified medical devices (CE class IIa) that attach as add-ons to existing conventional inhalers without the need of changing the design or the aerodynamic behaviour of the inhaler flow path. The data collected by the sensors is critical for understanding the real-life use and the effectiveness of inhaled medications, and for the development of interventions promoting adherence and correct inhaler technique.
Also, we use deep learning and software applications to deliver data-driven therapies. A patient mobile application provides personalized support to help simplify the management of the treatment, control the disease and improve the patient experience. A professional-oriented dashboard empowers healthcare professionals through a rich source of data and advanced suggestions for them to make smarter decisions, drastically improving clinical efficiency and quality.
Founded in 2015, backed by Breed Reply and Sanner Ventures, Amiko is now serving commercial, institutional, and individual customers in Italy, Portugal, Germany, Netherlands and the UK, and growing to become a global provider of advanced respiratory care solutions, empowering patients, healthcare professionals, and payers to realize a shared vision of a digital health enabled future.
More information

Investors

Admin
FICHe Follow the Future Internet CHallenge eHealth!

Recommendations